Nyenwe, Ebenezer
7 papers on CoChatORCID 0000-0003-2742-1262
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes
Espeland, M. A., Glick, H. A., Bertoni, A., Brancati, F. L., Bray, G. A., Clark, J. M., Curtis, J. M., Egan, C., Evans, M., Foreyt, J. P., et al. (2014) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Education
Cited by 174
- Verified
Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients
Gallagher, D., Kelley, D. E., Thornton, J., Boxt, L., Pi-Sunyer, X., Lipkin, E., Nyenwe, E., Janumala, I., & Heshka, S. (2017) · The American Journal of Clinical Nutrition
Diabetes, Cardiovascular Risks, and LipoproteinsNutrition and Health in Aging
Cited by 50
- Verified
The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 29
- Verified
Nonalcoholic fatty liver disease and metabolic syndrome in hypopituitary patients
Nyenwe, E. A., Williamson-Baddorf, S., Waters, B., Wan, J. Y., & Solomon, S. S. (2009) · The American Journal of the Medical Sciences
Hormonal and reproductive studiesLiver Disease Diagnosis and Treatment
Cited by 28
- Verified
Multi-year reproducibility of hyperinsulinemic euglycemic clamp-derived insulin sensitivity in free-living adults: association with incident prediabetes in the pop-abc study
James, D., Umekwe, N., Edeoga, C., Nyenwe, E., & Dagogo-Jack, S. (2020) · Metabolism
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free